Glucagon and Thyroid Hormone: A Championship Team Alan Saghatelian, Ben Cravatt Cell Volume 167, Issue 3, Pages 604-605 (October 2016) DOI: 10.1016/j.cell.2016.10.008 Copyright © 2016 Elsevier Inc. Terms and Conditions
Figure 1 Glucagon and Thyroid Hormone T3 Have Beneficial Effects on Energy Expenditure and Dyslipidemia As monotherapies these hormones also produce deleterious effects, including hyperglycemia for glucagon and cardiomyopathy and bone loss for T3. Finan et. al. synthesized glucagon/T3, a covalent peptide-small molecule fusion of glucagon and T3, that retains the beneficial characteristics of these individual hormones while avoiding negative side effects. Cell 2016 167, 604-605DOI: (10.1016/j.cell.2016.10.008) Copyright © 2016 Elsevier Inc. Terms and Conditions